Market Overview

Facebook Falls After Missing Q2 Sales Estimates

Share:
Facebook Falls After Missing Q2 Sales Estimates
Related FB
FANG Weakness Drags New Communication Services ETFs
Midterms And The Stock Market: Potential Winners, Losers From The Coming Election
Reuters: Facebook tightens ban on inaccurate polling, voting information (Seeking Alpha)

Facebook, Inc. (NASDAQ: FB) shares plummeted following the release of the company’s second-quarter earnings.

The world’s biggest social media company reported earnings of $1.74 per share, beating estimates by 2 cents. Revenues fell short of estimates, however, coming in at $13.03 billion, missing by $322 million.

"Our community and business continue to grow quickly," said CEO and Founder Mark Zuckerberg. "We are committed to investing to keep people safe and secure, and to keep building meaningful new ways to help people connect."

Click here to see the full results.

Q2 Highlights

  • Daily Active Users were 1.47 billion, up 11 percent year-over-year;
  • Monthly Active Users were 2.23 billion, up 11 percent year-over-year;
  • Mobile advertising represented 91 percent of total advertising revenue, up from 87 percent in the same quarter of last year; and
  • The company had $42.31 billion in cash and cash equivalents at the end of Q2.

At time of publication, Facebook's stock traded around $200.69, down 7.6 percent in the after-hours session. Twitter Inc (NYSE: TWTR) was also moving lower.

During the company's conference call, Facebook's sell-off accelerated. The stock was down more than 23 percent as of 5:50 pm. ET, after the company warned it sees QoQ high-single digit sales growth decelerating in the second half of the year.

Related Links:

Facebook's Q2 Earnings: What To Expect

Tech Strategist: Twitter Is The Main Beneficiary Of Facebook's Privacy Scandal

Posted-In: Mark ZuckerbergEarnings News Top Stories After-Hours Center Movers Trading Ideas Best of Benzinga

 

Related Articles (FB + TWTR)

View Comments and Join the Discussion!

Aurora Closes On $2.5B Purchase Of MedReleaf

Deutsche Bank's Q2 Earnings Outlook